https://pages.htgaa.org/2026a/fiona-connolly/homework/week-13-bio-design-living-materials/index.htmlWeek 13 — AI, SynBio, and Scaling Health Innovation (ARPA-H) Why most synthetic-biology breakthroughs never become products — and what observability of the lab bench can do about it At a glance. Modern synthetic biology has a discovery surplus and a scaling deficit. We can engineer cells to make almost anything; we cannot reliably get those protocols to run in a second lab, a contract manufacturer, or a robot without burning a year on tech transfer.Hugoen